Via Canna Reporter
The International Medical Cannabis Conference Bern (IMCCB-25), which will take place on 13 and 14 February 2025 at the University of Bern, Switzerland, will bring together some of the world’s leading researchers to discuss advances in the research and application of medicinal cannabis. The event, chaired by Professors Jürg Gertsch and Rudolf Brenneisen, promises to be a crucial meeting point for the scientific community, physicians and specialists in the field of medicinal cannabis, as it will highlight the scientific and clinical advances in cannabis in a medical context.
The event is structured to provide an experience rich in scientific knowledge and exchange of ideas on topics such as pharmacology, new methodologies for the study of cannabis and its active compounds, medical indications and clinical applications, use of cannabis in palliative care and chronic pain, treatment in geriatrics, psychiatry and women’s health, among others.
In addition to these more scientific topics, the conference will also include some regulatory and legal considerations of cannabis, as well as its technological aspects and innovations, development of new products and technologies in the cannabis pharmaceutical industry and advanced analysis and safety techniques.
Among the confirmed keynote speakers are some of the world’s leading experts in the field:
- Daniele Piomelli (University of California, Irvine, USA), who will open the conference with a talk “The Day Anandamide Almost Died and Other Endocannabinoid Stories”, exploring the most remarkable discoveries about the endocannabinoid system.
- Vincenzo Di March (Université Laval, Quebec, Canada), which will address the “Endocannabinoid Signaling: From the Gut to the Brain and Across Different Kingdoms”, highlighting the intersections between natural cannabinoids and the endocannabinoid dome.
- Guillermo Moreno-Sanz (Khiron Europe, Spain), which will discuss “Personalized Cannabis Medicines – What’s the Evidence?”, bringing a perspective on the future of cannabis-based precision medicine.
- David Finn (University of Galway, Ireland), with the lecture “Sites and Mechanisms Underlying Cannabinoid-Induced Antinociception”, focused on advances in pain management.
- Kirsten Müller-Vahl (Medizinische Hochschule Hannover, Germany), which will present “CBMs in Sleep Disorders”, exploring the potential of cannabis-based medicines to improve patients’ quality of life.
- Mahmoud ElSohly (University of Mississippi, USA), one of the most important phytochemists in the field, will address advances in 50 years of phytochemistry and cannabis analysis, bringing a historical and technical perspective on scientific development.
- Anne Katrin Schlag (Drug Science & Imperial College London, United Kingdom), which will address the topic “The Value of Real-World Evidence in Cannabis Therapies”, exploring how real-world data can shape medical regulation and practice.
- Marcus Weber (Cantonal Hospital of St. Gallen, Switzerland), who will discuss “Cannabinoids for Neurodegeneration – Fact or Fiction?”, highlighting the evidence on the use of cannabinoids in the treatment of neurological diseases.
- Sandra Carrillo (Cannabis Doctors Colombia, Colombia), a pioneering physician in clinical practice with medicinal cannabis, who will present the challenges and advances in the therapeutic application of the plant in emerging countries.
The conference will also feature roundtables, interactive sessions, poster presentations and panel discussions, providing a unique platform for the exchange of ideas and networking. Registration is now open and more information can be found at official website.
